Qifeng F. Wang

No. 270, Dong An Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications

Retraction Note: The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma.

Retraction Note: The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma.

Journal: Nature communications
Published: August 19, 2026

Kinase Fusions Define a Distinct Subset of BRAF V600E‑Negative Metanephric Adenomas: A Multi-Institutional Study of 7 Cases.

Kinase Fusions Define a Distinct Subset of BRAF V600E‑Negative Metanephric Adenomas: A Multi-Institutional Study of 7 Cases.

Journal: The American journal of surgical pathology
Published: June 23, 2026

Cancer of unknown primary: the evolution of tissue of origin identification in the artificial intelligence era.

Cancer of unknown primary: the evolution of tissue of origin identification in the artificial intelligence era.

Journal: Biomarker research
Published: April 02, 2026

Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a phase II trial.

Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a phase II trial.

Journal: Nature communications
Published: January 04, 2026

A long-term retrospective evaluation of pulpectomy and calcium hydroxide/iodoform paste resorption in primary teeth managed under dental general anaesthesia.

A long-term retrospective evaluation of pulpectomy and calcium hydroxide/iodoform paste resorption in primary teeth managed under dental general anaesthesia.

Journal: European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry
Published: November 01, 2025

Multimodal parameters for the diagnosis of putative primaries of cancer of unknown primary.

Multimodal parameters for the diagnosis of putative primaries of cancer of unknown primary.

Journal: iScience
Published: October 16, 2025

Deepath-SCC: a deep learning model for accurate tissue origin identification in squamous cell carcinoma.

Deepath-SCC: a deep learning model for accurate tissue origin identification in squamous cell carcinoma.

Journal: NPJ precision oncology
Published: September 12, 2025

Machine learning-driven proteomics classifier deciphers tumor origins of primary and metastatic squamous cell carcinomas.

Machine learning-driven proteomics classifier deciphers tumor origins of primary and metastatic squamous cell carcinomas.

Journal: Biomarker research
Published: September 01, 2025

Deepath-MSI: a clinic-ready deep learning model for microsatellite instability detection in colorectal cancer using whole-slide imaging.

Deepath-MSI: a clinic-ready deep learning model for microsatellite instability detection in colorectal cancer using whole-slide imaging.

Journal: NPJ precision oncology
Published: April 30, 2025

Mutational landscape and DNA methylation-based classification of squamous cell carcinoma and urothelial carcinoma.

Mutational landscape and DNA methylation-based classification of squamous cell carcinoma and urothelial carcinoma.

Journal: Clinical epigenetics
Published: January 12, 2025

MRI Radiomics Signatures of 21-Gene Recurrence Score for Predicting Survival in ER+/HER2- Breast Cancer.

MRI Radiomics Signatures of 21-Gene Recurrence Score for Predicting Survival in ER+/HER2- Breast Cancer.

Journal: Cancer medicine
Published: December 03, 2024

Case Report: Gefitinib in EGFR 19del recurrent aggressive fibromatosis.

Case Report: Gefitinib in EGFR 19del recurrent aggressive fibromatosis.

Journal: Frontiers in oncology
Published: December 01, 2024
Showing 1-12 of 99

Last Updated: 09/26/2026